Patients' Perspectives on the Use of the Montgomery-Asberg Depression Rating Scale Self-assessment Version in Primary Care
Overview
Affiliations
Objective: The aim of the current study was to better understand how patients with depression perceive the use of MADRS-S in primary care consultations with GPs.
Design: Qualitative study. Focus group discussion and analysis through Systematic Text Condensation.
Setting: Primary Health Care, Region Västra Götaland, Sweden.
Subjects: Nine patients with mild/moderate depression who participated in a RCT evaluating the effects of regular use of the Montgomery-Åsberg Depression Self-assessment scale (MADRS-S) during the GP consultations.
Main Outcome Measure: Patients' experiences and perceptions of the use of MADRS-S in primary care.
Results: Three categories emerged from the analysis: (I) confirmation; MADRS-S shows that I have depression and how serious it is, (II) centeredness; the most important thing is for the GP to listen to and take me seriously and (III) clarification; MADRS-S helps me understand why I need treatment for depression.
Conclusion: Use of MADRS-S was perceived as a confirmation for the patients that they had depression and how serious it was. MADRS-S showed the patients something black on white that describes and confirms the diagnosis. The informants emphasized the importance of patient-centeredness; of being listened to and to be taken seriously during the consultation. Use of self-assessment scales such as MADRS-S could find its place, but needs to adjust to the multifaceted environment that primary care provides. Key Points Patients with depression in primary care perceive that the use of a self-assessment scale in the consultation purposefully can contribute in several ways. The scale contributes to Confirmation: MADRS-S shows that I have depression and how serious it is. Centeredness: The most important thing is for the GP to listen to and take me seriously. Clarification: MADRS-S helps me understand why I need treatment for depression.
Ivert L, Svedbom A, Lundqvist M, Wahlgren C, Bradley M, Johansson E Acta Derm Venereol. 2022; 102:adv00801.
PMID: 36193008 PMC: 9677256. DOI: 10.2340/actadv.v102.803.
Carfora L, Foley C, Hagi-Diakou P, Lesty P, Sandstrom M, Ramsey I PLoS One. 2022; 17(4):e0267030.
PMID: 35446885 PMC: 9022863. DOI: 10.1371/journal.pone.0267030.
Janssen-Aguilar R, Rojas P, Ruiz-Sanchez E, Rodriguez-Violante M, Alcantara-Flores Y, Crail-Melendez D Brain Sci. 2022; 12(3).
PMID: 35326281 PMC: 8945969. DOI: 10.3390/brainsci12030326.
Hulten A, Bjerkeli P, Holmgren K BMJ Open. 2021; 11(3):e041157.
PMID: 33753430 PMC: 7986880. DOI: 10.1136/bmjopen-2020-041157.
Nejati S, Ariai N, Bjorkelund C, Skoglund I, Petersson E, Augustsson P Int J Gen Med. 2020; 13:177-183.
PMID: 32523369 PMC: 7234955. DOI: 10.2147/IJGM.S243150.